Ø Generate CTA/NDA package including timeline, action plan, task tracking log, etc. for other project leads;
Ø Gather local development needs through attending local asset team meetings and interating with other functions, propose China strategy/timeline for your projects, compare local and global plans, identify any gaps between them, highlight risk, and propose mitigation plans;
Ø Ensure PharmSci China plan for your projects, including timing of key PharmSci deliverables and associated resource/budget forecasts are consistent with candidate milestones, overall Pfizer China and PharmSci development strategies
Ø PhD with technical experiences in drug development disciplines such as API, DP, Analytical, Quality etc.;
Ø Able to fluently communicate in Chinese and English and work outside normal working hour;
Ø Portfolio management skills related to project strategies, timeline, resource, and budgets.
Ø Fluent in English & Mandarin (written/spoken); adept at technical discussions in both languages.
Ø Strong risk management ability: gap analysis, mitigation planning, and scenario forecasting.
Ø Proficiency with project management tools (e.g., MS Project, Smartsheet, JIRA).
Ø Flexibility to work outside standard hours for global team collaboration.
Ø Proactive problem-solver with strategic agility.
Ø Able to navigate ambiguity in a matrixed MNC environment.
Ø Committed to accelerating patient access in China.

Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance.
Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the combination of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in more than 30 countries throughout the world.